Tianyin Pharmaceutical Co, Inc. to Report 2008 Fiscal Fourth Quarter and Year End Results

CHENGDU, China, Sept. 23 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., , a manufacturer and supplier of modernized traditional Chinese medicine (“TCM”) based in Chengdu, China, today announced that management will hold a conference call at 9:00 A.M. EDT on Monday, September 29, 2008, to discuss its 2008 fiscal fourth quarter and year end results. Financial results will be released that day before the market opens.

Interested parties may access the call by dialing 800-762-8795 from within the United States, or 480-629-9031 if calling internationally. The conference ID is 3924338. It is advisable to dial in approximately 5-10 minutes prior to the start of the call. A replay will be available through October 13, 2008 and can be accessed by dialing 800-406-7325 (U.S.), 303-590-3030 (Int’l), passcode 3924338.

This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid’s website at http://viavid.net or at the following link: http://viavid.net/dce.aspx?sid=00005691 . The web cast can be accessed until October 29, 2008. To access the web cast, you will need to have the Windows Media Player on your desktop. For the free download of the Media Player please visit: http://microsoft.com/windows/windowsmedia/en/download/default.asp .

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized Traditional Chinese Medicine (“TCM”) in China. It was established in 1994 and acquired by the current management team in August 2003. It has a comprehensive product portfolio of 33 modernized TCMs and 4 generic western medicines in the market, 22 of which are listed in the highly selective National Medicine Catalog of the National Medical Insurance Program. Tianyin owns and operates two GMP manufacturing facilities and an R&D platform supported by leading Chinese academic institutions. The Company has a pipeline of 48 pharmaceutical products pending approval. Tianyin has an extensive nationwide distribution network throughout China with a sales force of 720 salespeople. Tianyin is headquartered in Chengdu, Sichuan Province with two manufacturing facilities and a total of 1,384 employees. Tianyin achieved revenue of $20.4 million and net income of $3.95 million in FY2007 ending June 30, 2007. For more information about Tianyin Pharmaceuticals, please visit http://tianyinpharma.com .

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company’s filings with the Securities and Exchange Commission.

CONTACT: For the Company: Allen Tang, Ph.D., MBA, Assistant to the CEO,
+86-158-2122-5642 (China), or Allen.y.tang@gmail.com; or Investors: Alan
Sheinwald of HC International, Inc., +1-914-669-0222 (U.S.), or
Alan.Sheinwald@hcinternational.net

Web site: http://www.tianyinpharma.com/
http://viavid.net/

MORE ON THIS TOPIC